Dermatitis

Westlake Village-based immune-dermatology company Arcutis Biotherapeutics Inc. has received federal approval to begin marketing its drug to treat a type of dermatitis in children ages 6 to 11. The company had already received approval to market the drug for use in people 12 and over. Separately, the company this month announced a public offering of $100 million […]